Don't Miss By STAT staff What will 2020 bring for medicine and science? We asked 16 leaders for predictions
Don't Miss By Eric Boodman Night sweats, bloody cough — and a diagnosis that turned a doctor into an activist
Special Report By Carl Zimmer ‘Game of Genomes’ Season 2: Adventuring deep into the mysterious wilderness of our DNA
Don't Miss By Casey Ross Hospitals are throwing out organs and denying transplants to meet federal standards
Special Report By Lev Facher First-of-its-kind examination shows how widely pharma showers campaign cash at the state level
Special Report By Lev Facher Pharma is showering Congress with cash, even as drug makers race to fight the coronavirus
Don't Miss By STAT STAT Madness voting ends tonight. Cast your vote for the best innovations in biomedicine
Don't Miss By STAT staff We wish we’d written that: STAT staffers share their favorite stories of 2019
Don't Miss By Alissa Ambrose ‘You keep loving each other’: A window into dementia at the end of a lifelong partnership
Don't Miss By Sharon Begley What’s in the cards for this year’s Nobel Prizes? Scientists are placing their bets
Don't Miss By Rebecca Robbins With time ticking away, clinicians scramble to save newborn twins from the disease that took their brother
Don't Miss By STAT staff We wish we’d written that: STAT staffers share their favorite stories of 2018
Don't Miss By Eric Boodman Font of despair: In the fierce competition for science funding, even a typeface glitch can be fatal
Don't Miss By Helen Branswell, Adam Feuerstein, and Damian Garde BIO in 30: A new biotech from Gates, Bradner on data science, & bienvenue à Cambridge
Don't Miss By Damian Garde and Rebecca Robbins BIO in 30: The mechanics of drug prices, a new world record, & a very Canadian table hockey game
Don't Miss By Helen Branswell, Adam Feuerstein, and Rebecca Robbins BIO in 30: Combating sepsis, questioning Right to Try, & the existential dread of a mid-level exec
Don't Miss By Casey Ross and Rebecca Robbins BIO in 30: Knock on ‘fast followers,’ all about Hong Kong, & Sculley’s next stop
Don't Miss By Sharon Begley and Adam Feuerstein ASCO in 30: Wall Street’s reaction & patient-reported outcomes